Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | ESR1 | P03372 | 1/20 | 0.31 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.31 |
| ▸ | PGR | P06401 | 1/20 | 0.31 |
| ▸ | AR | P10275 | 1/20 | 0.31 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3564666 | 0.85 | CCNB2 (0.31) | — | |
| SCHEMBL31367048 | 0.77 | RAB9A (0.31) | RAB9A | |
| SCHEMBL13262184 | 0.77 | HPGD (0.34) | RAB9AALDH1A1 | |
| SCHEMBL3574837 | 0.76 | DRD3 (0.33) | — | |
| SCHEMBL6208359 | 0.76 | — | — | |
| SCHEMBL601887 | 0.76 | GAA (0.30) | — | |
| SCHEMBL23802251 | 0.76 | ALDH1A1 (0.34) | ALDH1A1 | |
| SCHEMBL15459089 | 0.75 | EDNRB (0.31) | ALDH1A1 | |
| SCHEMBL30169612 | 0.72 | HTR2C (0.37) | ALDH1A1MAPK1 | |
| SCHEMBL16955827 | 0.72 | HTR2C (0.37) | ALDH1A1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108047025-B | Preparation method of 3-aldehyde-5-methylbenzoic acid | 珠海奥博凯生物医药技术有限公司 | 2020-08-04 | — | — | CN | claimed |
| EP-3218341-B1 | PHENYL BASED COMPOUNDS SUBSTITUTED WITH ALDEHYDE MOIETIES AND THEIR USE IN PERFUMERY | GIVAUDAN SA (CH) | 2024-05-01 | — | — | EP | disclosed |
| US-RE49502-E1 | Phenyl based compounds substituted with aldehyde moieties and their use in perfumery | GIVAUDAN SA (CH) | 2023-04-25 | — | — | US | disclosed |
| CN-107074713-B | Phenyl-based compounds substituted with aldehyde moieties and their use in perfumery | 奇华顿股份有限公司 | 2021-03-26 | — | — | CN | disclosed |
| CN-108047025-B | Preparation method of 3-aldehyde-5-methylbenzoic acid | 珠海奥博凯生物医药技术有限公司 | 2020-08-04 | — | — | CN | disclosed |
| US-10443018-B2 | Phenyl based compounds substituted with aldehyde moieties and their use in perfumery | GIVAUDAN S.A. (CH) | 2019-10-15 | — | — | US | disclosed |
| US-20170298291-A1 | Phenyl Based Compounds Substituted with Aldehyde Moieties and their Use in Perfumery | GIVAUDAN S.A. (CH) | 2017-10-19 | — | — | US | disclosed |
| US-20170298291-A1 | Phenyl Based Compounds Substituted with Aldehyde Moieties and their Use in Perfumery | GIVAUDAN S.A. (CH) | 2017-10-19 | — | — | US | disclosed |
| US-20170298291-A1 | Phenyl Based Compounds Substituted with Aldehyde Moieties and their Use in Perfumery | GIVAUDAN S.A. (CH) | 2017-10-19 | — | — | US | disclosed |
| EP-3218341-A1 | PHENYL BASED COMPOUNDS SUBSTITUTED WITH ALDEHYDE MOIETIES AND THEIR USE IN PERFUMERY | Givaudan S.A. (CH) | 2017-09-20 | — | — | EP | disclosed |
| WO-2017117538-A1 | META-AZACYCLIC AMINO BENZOIC ACID DERIVATIVES AS PAN INTEGRIN ANTAGONISTS | SAINT LOUIS UNIVERSITY (US) | 2017-07-06 | — | — | WO | disclosed |
| WO-2016074865-A1 | PHENYL BASED COMPOUNDS SUBSTITUTED WITH ALDEHYDE MOIETIES AND THEIR USE IN PERFUMERY | GIVAUDAN SA (CH) | 2016-05-19 | — | — | WO | disclosed |
| WO-2016074865-A1 | PHENYL BASED COMPOUNDS SUBSTITUTED WITH ALDEHYDE MOIETIES AND THEIR USE IN PERFUMERY | GIVAUDAN SA (CH) | 2016-05-19 | — | — | WO | disclosed |
| WO-2016074118-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2016-05-19 | — | — | WO | disclosed |
| US-9085606-B2 | Beta amino acid derivatives as integrin antagonists | SAINT LOUIS UNIVERSITY (US) | 2015-07-21 | — | — | US | disclosed |
| US-20140038910-A1 | Beta Amino Acid Derivatives as Integrin Antagonists | SAINT LOUIS UNIVERSITY (US) | 2014-02-06 | — | — | US | disclosed |
| US-20110184029-A1 | PYRIDONE DERIVATIVES AS NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2011-07-28 | — | — | US | disclosed |
| US-20110184029-A1 | PYRIDONE DERIVATIVES AS NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2011-07-28 | — | — | US | disclosed |
| US-20110184029-A1 | PYRIDONE DERIVATIVES AS NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2011-07-28 | — | — | US | disclosed |
| WO-2010009047-A1 | PYRIDONE DERIVATIVES AS NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2010-01-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140038910-A1 | Beta Amino Acid Derivatives as Integrin Antagonists | ITGB2, ITGAL, ITGB1 | RAB9A 861/4885ALDH1A1 919/4885MAPK1 1584/4885 |
| US-20110184029-A1 | PYRIDONE DERIVATIVES AS NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS | DPYD, TYMP, PNPO | RAB9A 4274/4885ALDH1A1 460/4885MAPK1 1543/4885 |
| US-10443018-B2 | Phenyl based compounds substituted with aldehyde moieties and their use in perfumery | C5, C9, CBR3 | RAB9A 4288/4885ALDH1A1 245/4885MAPK1 1632/4885 |
| US-20170298291-A1 | Phenyl Based Compounds Substituted with Aldehyde Moieties and their Use in Perfumery | C5, C9, CBR3 | RAB9A 4288/4885ALDH1A1 245/4885MAPK1 1632/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.